KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
↓ Download CSV- Sector Manufacturing
- Incorporated D0
- Fiscal year ends Apr 30
In fiscal 2026, KESTRA MEDICAL TECHNOLOGIES, LTD. reported revenue of $95.13M, up 59.0% from the prior year. The company ran a net loss, with a net margin of -138.4% and a gross margin of 51.4%. It held $358.46M in total assets against $98.81M in total liabilities.
Key ratios (FY2026)
51.4%
Gross margin
-141.6%
Operating margin
-138.4%
Net margin
-50.7%
Return on equity
+59.0%
Revenue growth (YoY)
| Metric (FY) | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $95.13M | $59.81M | $27.81M | — |
| Cost of Revenue | $46.26M | $35.60M | $27.45M | — |
| Gross Profit | $48.86M | $24.21M | $362.0K | — |
| Operating Income | -$134.74M | -$106.38M | -$85.06M | — |
| Net Income | -$131.61M | -$113.81M | -$94.12M | — |
| EPS (Diluted) | $-2.43 | $-5.13 | $-5.07 | — |
| Total Assets | $358.46M | $295.74M | $45.95M | — |
| Total Liabilities | $98.81M | $90.34M | $78.22M | — |
| Shareholders' Equity | $259.66M | $205.41M | -$209.38M | -$117.58M |
| Cash & Equivalents | $99.71M | $237.59M | $8.25M | — |
| Operating Cash Flow | -$81.70M | -$77.61M | -$72.23M | — |
| Capital Expenditures | $34.89M | $22.94M | $12.23M | — |
| Shares Outstanding | 58.38M | 51.35M | 105.8K | — |